GFAP and Cognitive impairment: More recent studies align with these findings, showing that WMH, a marker of CAA, and glial fibrillary acidic protein (GFAP), a marker of astrocytosis and neuroinflammation, are independently associated with progression from mild cognitive impairment (MCI) to dementia.28